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The development of novel X-ray contrast agents (XCAs) is being widely investigated. 
Nanoparticles for use as potential contrast agents is a heavily researched area because 
nanomaterials are able to generate a higher contrast image relative to a small molecule, have long 
blood circulation times, and allow for the addition of different functionalities such as a surface 
coating. Particularly bismuth nanoparticles are being considered as potential X-ray contrast 
agents because of bismuth’s high X-ray opacity and high biological tolerability. Furthermore, an 
SiO2 shell coating around bismuth nanoparticles can offer benefits in regards to nanoparticle 
colloidal stability in aqueous solution and in vivo biocompatibility. In this research, an aerobic 
synthesis of elemental bismuth nanoparticles and subsequent silicon dioxide coating protocol is 
examined in order to examine the reproducibility and feasibility of developing uniform silicon 
dioxide coated bismuth nanoparticles. TEM analysis was conducted and the images were 
analyzed for particle size distribution, shell thickness, and shape. The results of the elemental 
bismuth preparation trials show reproducibility in producing nanoparticles with narrow 
polydispersity within a range of 40-80 nm, but do not show reproducibility in producing size 
consistent bismuth nanoparticles. The average bismuth nanoparticle size was found to be 58.35 
nm ± 13.47. The SiO2 procedure results showed that there was a positive association observed 
between silicon dioxide shell thickness and 25, 50, and 100 µL of Tetraethyl orthosilicate 
(TEOS) amounts with a limiting effect and that the procedure was effective in coating BiNPs 
uniformly with small variabilities. Both procedures could be improved and the limitations could 
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1. Introduction- Background and Significance 
a. X-ray Radiography- Since being discovered in 1895, X-rays have become a significant 
diagnostic tool.1 X-rays have allowed medical professionals to obtain an internal noninvasive 
visualization of the human body, which has allowed for incredible progress in medical imaging 
and its application.1 The X-ray technique has revolutionized medicine and has provided the 
medical community inexpensive and high resolution images.1 X-ray Radiography involves using 
a contrast agent to show the physiology or metabolism of the patient internally.2 An X-ray image 
is created by giving a short exposure of X-ray radiation to the patient, that is then represented on 
a film or detector.3 Computed Tomography (CT), which integrates different X-ray images, 
comprises 75% of the imaging conducted today.1 The field of medical imaging is rapidly 
expanding. More than 80 million CT scans are performed per year and the number continues to 
grow at approximately 10% per year, compared to only 3 million CT scans in 1980.4 Figure 1.1 
displays examples of medical X-ray images. 
A                                              B                                 C 
   
Figure 1.1 Medical X-ray Images5,6,7 








b. X-ray Attenuation  
The production of an X-ray image involves attenuation of X-ray radiation.3 Attenuation lowers 
the intensity of an X-ray beam as it passes through a material.8 The intensity can be lowered due 
to several reasons, which include absorption, energy transformation, or deflection of the 
photons.8 The extent of X-ray attenuation depends on the X-ray attenuation coefficient of the 
attenuating material or substance, µ, which can be calculated by the following formula: 
                                 
where  
µ = Attenuation Coefficient 
ρ = Density of the absorbing material  
Z = Atomic number of atoms in the material 
A = Atomic mass of atoms in the material 
E = energy of the incident X-ray 
 
The attenuation coefficient, µ, thus describes the amount of radiation that can be expected to be 
attenuated by a given absorbing material.8 According to Equation 1, since Z is directly 
proportional to µ, higher atomic number atoms give rise to greater X-ray attenuation. These 
typically include heavy transition metals, such as bismuth or gold.3  
 
c. Contrast Agents 
X-ray contrast agents consist of atoms, molecules, or compounds that are administered internally 
to a patient for imaging purposes.3 The current X-ray contrast agents used most widely are 
barium sulfate and iodinated molecules.1 An estimated 5 million X-ray procedures are conducted 




patient’s GI tract as a mostly undissolved solid.1,3 Iodinated molecules have a short circulation 
time, rapid clearance, and an increased risk of causing thyroid dysfunction but are commonly 
used for vascular imaging since they are soluble in aqueous media.3,9 There are negative side 
effects associated with traditional contrast agents. Most deaths from contrast media were 
correlated with renal failure, nephropathy, anaphylaxis or allergic reactions.10 This has created a 
need to replace traditional X-ray contrast media. Specifically contrast media that are less toxic, 
less costly, and with longer circulation times are among the characteristics suggested. The 
development of novel X-ray contrast media motivates this research.   
 
d. Nanoparticles as Contrast Agents 
Nanoparticles are typically spherical materials that are between 1 to 100 nm in size and show 
potential for imaging purposes.9 Nanoparticles as contrast agents are used for several reasons. 
Nanoparticles can allow generation of a higher contrast image relative to a small molecule, have 
long blood circulation times, have feasible syntheses, and allow for the addition of different 
properties such as a shell surface coating.9 Nanoparticles contain a large number of X-ray 
attenuating atoms within a small volume, which would allow for them to be given to a patient 
internally at a low concentration.11 Specifically, elements that have a higher Z value, such as gold 
and bismuth, are used as nanoparticle X-ray contrast agents because of their high X-ray opacity.9 
Gold nanoparticles have been researched as potential contrast agents. However gold 






e. Bismuth Nanoparticles 
Bismuth nanoparticles (BiNPs) as potential X-ray contrast agents are the focus of this work. 
Bismuth is being considered as a contrast agent for multiple reasons. Bismuth has a high atomic 
number (Z=83) making it highly X-ray opaque and it is found to be biologically well- tolerated.13 
However, BiNPs are difficult to stabilize in aqueous environments due to their tendency to 
undergo oxidation and hydrolysis in water.13 Although this allows BiNPs to more easily degrade 
and be cleared through the kidneys, this serves as a challenge in synthesizing BiNPs that can be 
stabilized long enough for imaging purposes.13 
Gold nanoparticle synthesis research has helped to provide insight into bismuth 
nanoparticle synthesis. Therefore, we have developed, an aerobic method for the synthesis of 
elemental bismuth nanoparticles using bismuth iodide as a precursor. This method was 
developed to attempt to create more size uniform bismuth nanoparticles with greater 
reproducibility between replicate batches verses existing reports in the literature. Primarily, two 
syntheses conducted to form elemental bismuth nanoparticles previously were inspiration in 
development and optimization of this aerobic method. Wang et al. developed near monodisperse 
BiNPs between 3-115 nm in diameter by a simple approach using Bi[N(SiMe3 )2]3 and 
Na[N(SiMe3)2], and a polymer surfactant.
14 He et al. also developed highly monodisperse 
nanoparticles between 5-30 nm in diameter by using a simple approach that involved reacting the 
metal chloride precursor with a long chain amine and a strong base to form a metal-amide 
precursor that decomposed upon heating into the metal nanoparticle.15 The synthesis developed 
by He et al. can be applied to many metals, including bismuth.15 Although these syntheses 
provided useful insight into developing the bismuth nanoparticle synthesis used in this research, 
these syntheses were performed under strict anaerobic conditions.14,15 Conversely, the bismuth 
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nanoparticle synthesis developed by our group is able to be conducted under aerobic conditions 
and also avoids high temperatures or very reactive chemicals. One of the goals of this research is 
to examine the feasibility of conducting this synthesis in replicate to obtain enough product for 
contrast agent testing. Ideally, replicate syntheses would result in similar average diameters and 
standard deviations for the bismuth nanoparticle populations from different batches.  
 
f. Use of Silicon dioxide Shell Coating 
The use of core shell silicon dioxide coated nanoparticles has shown to serve multiple benefits in 
regards to stability and biological transport of nanoparticles. Additionally, a previous study 
entitled “Fluorescent Core-Shell Ag@SiO2 Nanocomposites for Metal-Enhanced Fluorescence 
and Single Nanoparticle Sensing Platforms” used silver core nanoparticles with SiO2 shell 
coating and found that the silica layer can offer “robustness, chemical inertness, and the 
versatility needed for the conjugation of biomolecules or fluorophores,” as well as protect the 
core and allow for metal enhanced fluorescence.16 Based on the results of the study, metal 
nanoparticles with core shell architecture may be able to yield increase enhancement of 
fluorescence signal and increase in particle detectability relative to hollow fluorescent 
nanobubbles (produced by dissolving the metal core by cyanide of the metal-SiO2 species).
15 The 
study specifically used a silver metal species.16 Additionally, the SiO2 may aid in the stabilization 
of storage for BiNPs. Since SiO2 is hydrolyzed in the body and is cleared through the kidneys, 
this could possibly stabilize bismuth against oxidation for the duration of imaging and allow for 
clearance after. Hence the benefits of a silicon dioxide coating are being considered for the 




2. Experimental Section  
Materials, Synthetic Preparations, Instrumentation, and Analysis Methods: 
a. Materials –Bismuth (III) Iodide (99.999%, Strem), di-isopropyl benzene (98%, Acros), 1-
hexadecylamine (90%, Technical Grade, Alfa Aesar), poly(1-vinylpyrrolidone)-graft-(1-
triacontene) (Sigma-Aldrich), hexane (ACS grade, Fisher), electrophoretically pure H2O (to 18 
MΩ·cm), ethanol (ACS grade, Fisher), isopropanol (99%, Fisher), 30% ammonium hydroxide, 
and tetraethoxysilane were purchased and used as received.  
 
b. Synthetic Preparation 
 
Elemental Bismuth Nanoparticle Synthetic Preparation:  
 
300 mg of bismuth iodide was weighed on a laboratory balance and added to a 100 mL one-neck, 
round flask. Then 4 mL of di-isopropylbenzene was added as 4 aliquots to the mixture using a 5 
mL pipette (for a total of 16 mL of di-isopropylbenzene). This mixture was then stirred with a 
magnetic stir bar and placed on a hot plate. The temperature was then increased to 180ºC and the 
reaction was held at this temperature for approximately 10 minutes. The reaction duration was 
measured with a stopwatch. A change in the solution color from colorless to orange was 
observed while heating the mixture to 180ºC. After 10 minutes, the heat was lowered to 100ºC 
using a stream of cool air. A dryer is used to cool the mixture. A purple gas (I2 gas) was observed 
to be released from the mixture during the evaporation or cooling process of the mixture. 
Subsequently, 345 mg of poly(1-vinylpyrrolidone)-graft-(1-triacontene) was weighed and added 
to the flask. Then, 3.75 g of hexadecylamine was also weighed and added to the flask. This 
mixture was kept on the hot plate for approximately 1 hour at 100ºC. During this 1 hour, an 
intensifying orange color solution was observed in the solution, indicative of the formation of a 
soluble precursor. Halfway through this 1 hour period, a cap was placed on the flask to stopper it. 
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After 1 hour, the heat was again increased to 180ºC. The time was monitored by a stopwatch for 
10 minutes. At 180ºC, the mixture began to change color from orange to dark black, which 
indicated nucleation and growth of BiNPs. After 10 minutes, the reaction was quenched by 
pouring the solution into a beaker containing electrophoretically pure H2O (to 18 MΩ·cm) at 
room temperature, terminates the growth of BiNPs.  
Bismuth Nanoparticle Isolation:  
Centrifugation was used to separate and isolate the bismuth nanoparticles that were synthesized. 
To accomplish this, 50 mL of hexane was added to the BiNP solution. The mixture was stirred 
with a magnetic stir bar. This mixture was then placed in a sonic bath for a few minutes to break 
up any large aggregates. The mixture was then equally divided into 2 centrifuge tubes. These 
tubes were then placed into the centrifuge for 10 minutes at a speed of 4.4 RPM.  
After 10 minutes, the liquid in the tubes was decanted into a beaker. Then, 25 mL of 
hexane and 15 mL of ethanol were added to both tubes. The tubes were then sonicated for a few 
minutes. The tubes were then placed back into the centrifuge for 10 minutes at a speed of 4.4 
RPM. These steps were then repeated at least twice or until the supernatant is colorless. The 
bismuth nanoparticles are resuspended in toluene for TEM analysis and subsequently into 
isopropyl alcohol for shell coating.  
Silicon dioxide Coating of the Bismuth Nanoparticles: 
To apply a silicon dioxide coating to the BiNPs, 1 mL of the synthesized BiNPs as a suspension 
in isopropyl alcohol was used and added to a 500-mL round bottom flask and stirred with a 
magnetic stir bar. A pipette was used to measure the 1 mL of BiNPs (unknown concentration). 
Then, 250 mL of isopropanol and 25 mL of electrophoretically pure H2O (to 18 MΩ·cm) at room 
temperature were added to the flask. A graduated cylinder was used to measure these amounts. 
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Subsequently, 4 mL of 30% ammonium hydroxide was added to this mixture using a pipette. A 
variable amount of TEOS (tetraethoxysilane) was then added to the mixture.  
This silicon dioxide coating was performed a total of three times on three different 
samples of BiNPs from the same batch. Each of the three times the silicon dioxide coating 
procedure was conducted, the TEOS amounts were varied. The TEOS amounts used were 25 µL, 
50 µL, and 100 µL. In each case, the TEOS was added 25 µL at a time with 5 minutes between 
the addition of the aliquots (for the 50 µL and 100 µL trials). After the addition of TEOS, the 
reaction mixtures were stirred for an additional 15 minutes. The reaction mixtures were then 
placed in a laboratory freezer (0ºC) for approximately 2 hours. At the end of the 2 hours, the 
solutions were colorless with a grey hue. Subsequently, the flasks were then placed in a sonic 
bath for a few minutes to mix the solutions. The solutions were then centrifuged to isolate the 
silicon dioxide coated bismuth nanoparticles. The SiO2 BiNP were immersed in ethanol for TEM 




Transmission electron microscopy (TEM) provides insight into nanoparticle structure and shape 
by transmitting a beam of electrons that interact with the nanoparticles as the beam moves 
through them.17 This interaction forms an image that can be magnified to view the nanoparticles 
more clearly.17 The BiNPs and the subsequent silicon dioxide coated BiNPs are assessed using 
transmission electron microscopy to obtain imaging of the nanoparticles for insight into the size, 
shape, and distribution. The following is the preparation needed for TEM analysis of the 
nanoparticle samples. A filter paper is placed on a watch glass. The TEM grid is carefully 
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removed from the TEM grid storage box using forceps. The TEM grid is placed on the filter 
paper with the carbon film side facing up. 4 µL of the nanoparticle sample is drawn into a 
micropipette. 1-2 drops of the nanoparticle sample are placed exactly on the TEM grid. This is 
then allowed to dry outside for approximately 5 minutes and in the oven for approximately 10 
minutes. After the drying process, the TEM grid is placed in the TEM grid storage box using 
forceps for TEM analysis. This marks the end of the preparation process of the sample for TEM 
analysis. The nanoparticle imaging was conducted on a Technai F20 TEM operating at 4500 eV.  
 
d. Analysis Methods:  
Image J: 
Image J software was used to find the size and size distribution for the BiNPs without shells and 
to find the shell thickness distribution for the BiNPs with SiO2. For finding the size and size 
distribution of the BiNPs without SiO2 coating, the software program was used to discern the 
nanoparticles from the background by considering image contrast in defining of particle 
boundaries. The scale was appropriately set to measure the diameter of these individual 
nanoparticles by the software program before the determination of individual nanoparticle 
boundaries. For manual measurements, individual particles were selected by eye (at random) and 
their boundaries identified. However, it was difficult for the software program to recognize 
overlapping nanoparticles, and most of those were left out of the sample size statistics, by 
deleting them manually from the data set. Also, the background was sometimes considered by 
the program to be small nanoparticles; these data points also were selectively eliminated 
(manually deleted). These were limitations in analyzing the nanoparticle size distribution that 
may have affected the mean nanoparticle diameter. Furthermore, SiO2 shell coating thickness 
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was also difficult to determine with the software program, since it was difficult for the software 
to correctly distinguish the location of the core shell interface. Hence these measurements needed 
to be taken individual by hand. Then for better accuracy, a scale was set, and each individual 
nanoparticle core diameter was measured by drawing a line through the center of the 
nanoparticle and measuring its length against the scale. The shell thicknesses were measured the 
same way. This allowed the experimenter to more accurately distinguish between the shell and 
the core nanoparticle. However, this method also introduced error in the measurements, that were 
due to the perception of the experimenter. Thus, neither method can be considered exactly 
accurate, but rather considered to be approximations that allow relative comparisons in the 





























3. Results and Discussion 
 
a. Analysis of BiNPs created using the elemental bismuth synthesis preparation 
 
 
Figure 2: TEM image of the first batch of BiNPs created using the elemental bismuth 





Figure 3: Particle size distribution for the TEM image from Figure 2. The graph displays the 
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Figure 4: TEM image of the second batch of BiNPs created using the elemental bismuth 




Figure 5: Particle size distribution for the TEM image from Figure 4. The graph displays the 
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Figure 6: TEM image of the third batch of BiNPs created using the elemental bismuth 
nanoparticle synthesis preparation. The box shows the sample of nanoparticles used for data 





Figure 7: Particle size distribution for the TEM image from Figure 6. The graph displays the 
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Table 1: Summary Table of BiNPs size distribution. Includes the mean, median, and standard 
deviation (S.D.) of nanoparticles (Mean 58.35 nm ±13.47). The coefficient of variation is 









Batch 1 39.37 7.71 19.6 
Batch 2 69.24 12.53                18.0 
Batch 3 66.45 16.00                24.0 
Mean of Batches 58.35       13.47                23.0 
 
 
Shape and appearance of BiNPs: Nanoparticles should be of a very similar shape for the 
synthesis to be reproducible at forming uniform BiNPs in terms of appearance. Comparing the 
shape of the nanoparticles from the TEM images in Figures 2, 4, and 6, it is seen that the shape 
of the nanoparticles is spherical in all the trials. This indicates that the BiNP synthesis is highly 
reproducible at producing uniform results in terms of shape.  
 
Size distribution of BiNPs: Three different trials were done to synthesize the BiNPs using the 
synthetic preparation described in the experimental section. Figures 3, 5, and 7 show the size 
distribution of bismuth nanoparticles for trials 1, 2, and 3 respectively. Figure 3 shows a majority 
of the nanoparticles concentrated between 40-50 nm. Figure 5 displays a graph similar to a 
standard normal distribution curve with a majority of the nanoparticles between 60-80 nm. 
Figure 7 also displays a graph similar to a normal distribution curve with a majority of the 
nanoparticles between 60-80 nm as well. These results show that the second and third trial results 
for the mean nanoparticle size distributions were much closer and more consistent in comparison 
to the first trial. The mean nanoparticle sizes were found to be 39.36 nm ± 7.71, 69.25 nm ± 
12.53 and 66.45 nm ± 16.00 for the first, second, and third trial respectively as seen in table 1. 
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The mean nanoparticle size of all three trials (58.35 nm ± 13.47) was found by calculating the 
average of the three trials conducted (displayed in table 1). It is also important to note that the 
average nanoparticle sizes are well below 100 nm (smaller nanoparticles may be used 
biologically). The target diameter is 50 nm however, because this size is ideal for administering 
an intravenous contrast agent. The mean diameter for all three trials (58.35 nm ± 13.47) is close 
to 50 nm and its standard deviation encompasses 50 nm. However, the average nanoparticle 
diameters of trials 1, 2, and 3 are not as close to 50 nm in comparison to the mean diameter and 
do not have standard deviations that encompass 50 nm. The majority of the bismuth 
nanoparticles among all three trials are between 40-80 nm based on the size distribution graphs 
(figures 3, 5, and 7). These results indicate that the synthesis is not highly reproducible in 
achieving exactly 50 nm bismuth nanoparticles, but is highly reproducible in producing 
nanoparticles within a specific range between 40-80 nm.   
There is some variability within and between each trial conducted. The coefficient of 
variations are 19.6%, 18%, and 24% for trials 1, 2, and 3 respectively as seen in table 1. The 
coefficient of variation for the mean of all three trials is 23%. Overall, the standard deviations 
and coefficient of variations do show narrow size polydispersity (in this research it is defined as 
less than 25% variation) within each trial and between all three trials. The variations are between 
19.6-24%, which are not relatively large in comparison to the small nanoparticle sizes. However, 
the mean nanoparticle sizes and size distributions for all three trials indicate that producing 
bismuth nanoparticles of a constant diameter is not reproducible (between and within different 
batches), despite the limited range in variation. Hence the synthesis is not reproducible in 
producing nanoparticles of the same size, however there is a high degree of reproducibility in the 
synthesis to produce nanoparticles that are of a narrow polydispersity.  
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As mentioned in the methods used for analysis (chapter 2), there were limitations in using 
Image J. Using Image J, it was difficult to completely separate overlapping nanoparticles in the 
TEM images, and those nanoparticles were excluded from the sample thus creating a reduction 
in sample size. Additionally, an important aspect to note that there is a difference in sample size 
between the three trials. Using a larger and identical sample size for all trials may allow to 
decrease the coefficient of variation and standard deviation, which may show a greater degree of 
reproducibility and uniformity in the size of the nanoparticles. These trials are subject to 
experimental errors such as timing, measurement of materials, and variations in the instruments 
(mass scale and hotplate primarily). Hence multiple trials may lower the variations seen in 
results and show a greater degree of reproducibility of the synthetic bismuth preparation in 
producing size uniform and monodisperse nanoparticles. Additionally, despite limitations and 
sources of error, there may be improvements that can be made to the synthesis in order to 





















Figure 9: Core nanoparticle diameter distribution from the Figure 8 TEM image. The frequency 



























Figure 10: SiO2 Shell thickness distribution from the Figure 8 TEM image (N=30). The 
frequency represents the percent of shell thickness measurements within each range of the total 
sample size. Multiple shell thickness measurements were taken for each nanoparticle in Figure 8, 
because the shell thicknesses varied around each nanoparticle.  
 
 

























Figure 12: Core nanoparticle diameter distribution from the Figure 11 TEM image. The 




Figure 13: SiO2 Shell Thickness distribution of Figure 11 TEM Image (N=30). The frequency 
represents the percent of shell thickness measurements within each range of the total sample size. 
Multiple shell thickness measurements were taken for each nanoparticle in Figure 11, because 




















































Figure 15: Core nanoparticle diameter distribution from Figure 14 TEM image. The frequency 
























Figure 16: SiO2 shell thickness distribution from Figure 14 TEM Image (N=30). The frequency 
represents the percent of shell thickness measurements within each range of the total sample size. 
Multiple shell thickness measurements were taken for each nanoparticle in Figure 14, because 
the shell thicknesses varied around each nanoparticle.  
 
 
Table 2: Core Diameter: Summary table of statistical values for core diameter for all batches. 
The mean is 78.59±3.97 for the core diameter of all batches of nanoparticles. The coefficient of 








Batch 1 72.98 9.96 13.6% 
Batch 2 81.11 12.37 15.3% 
Batch 3 81.67 6.16 7.5% 
Mean of Batches 78.59 3.97 5.0% 
 
 
Table 3: SiO2 Shell Coating: Summary table of statistical values for shell thicknesses for all 
batches. The coefficient of variation is calculated by dividing the standard deviation by the mean.  
 
 Mean (nm) S.D. (nm) 
Coefficient of 
Variation (%) 
Batch 1 51.86 2.65 5.1% 
Batch 2 11.24 1.24 11.0% 

























Figure 17: TEOS amount effect on silicon dioxide shell coating thickness 
 
 
Shape and Appearance: The TEM Images of the SiO2-coated BiNPs are able to clearly show the 
shell coating, thickness and the core nanoparticle. The shape of the SiO2-coated BiNPs can be 
seen as circular. The added SiO2 coating increases the diameter and size of the nanoparticles as a 
whole. From Figures 8, 11, and 14 it can be seen that the SiO2 shell thickness varies based upon 
the amount of TEOS added. Figure 17 displays this relationship and shows a positive association 
for increasing shell thickness with increasing TEOS.  
 
Size Distribution of Core BiNPs: Figures 9, 12, and 15 display the size distribution for the core 
nanoparticle diameter for batch 1, 2, and 3 respectively. In figures 9, 12, and 15, it can be seen 
that the core nanoparticle size distributions are primarily centered around 70-90 nm in diameter.  
The average core size diameter for all the samples was found to be 78.59 ± 3.97 nm (seen in 
table 2). The coefficient of variability is 5% for the average core size diameter. From table 2, it 
can be seen that the standard deviations and the coefficient of variations are both low and 



































between 5-15.3%. It is interesting to note that this average core diameter size is higher than the 
mean BiNP nanoparticle diameter from Table 1, which is 58.35 nm ± 13.47. It is challenging to 
achieve uniform nanoparticle sizes with the bismuth synthesis. The synthesis may need 
improvements made to it to achieve more consistent core nanoparticle sizes in every batch 
produced as well as over multiple batches.  
 
SiO2 Shell Thickness: The shell thickness distributions are shown in figures 10, 13, and 16 for 
batch 1, 2, and 3 respectively. Figure 10 shows the shell thickness coating distribution to be 
between 46-66 nm for 100 µL of TEOS. Figure 13 shows the shell thickness distribution to be 
between 8-14 nm for 50 µL of TEOS. Figure 16 shows the shell thickness distribution to be 
between 8-13 nm for 25 µL of TEOS. Table 3 displays the average shell thickness of different 
batches of BiNPs that used different TEOS amounts. From Table 3, the average shell thicknesses 
were 51.86 ± 2.65 nm, 11.24 nm ± 1.34, and 10.59 ± 1.38 nm for the 100 µL, 50 µL, and 25 µL 
of TEOS amounts respectively. These results indicate there is very significant difference in the 
shell coating thickness of the TEOS amount of 100 µL in comparison to the 50 and 25 µL 
amounts. This is indicative of TEOS contributing toward the formation of the SiO2 shell coating. 
However, there is a very small difference in SiO2 shell thickness between the 50 µL and 25 µL 
of TEOS amounts. This relationship is also displayed in figure 17. This could be because the 
TEOS may have a limiting effect on shell thickness when smaller amounts are used. Only three 
data trials were used to create this graph, hence more data points may help to further examine 
this hypothesis and relationship.  
From the TEM Image in Figure 8, it can be seen the TEOS is present in excess (with the 
100 µL of TEOS) and overly coats the SiO2 nanoparticles. Much of the excess TEOS did not 
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coat the bismuth nanoparticles. Excessive coating may be unnecessary and may impact the 
functionality of the BiNPs. It is ideal to have a greater volume of the nanoparticles be composed 
of bismuth rather than the SiO2, because the heavy metal bismuth allows for greater X-ray 
attenuation.3,8 Therefore, smaller TEOS amounts that sufficiently coat the nanoparticle (without 
excess shell coating) are ideal.  
The coefficient of variability is 5%, 11%, and 13% for batch 1, 2, and 3 respectively. 
These variabilities are small, particularly for batch 1 which is 100 µL of TEOS. The coefficients 
of variability and low standard deviations show that the silicon dioxide shell coating procedure is 
able to uniformly coat the bismuth nanoparticles for each TEOS batch amount with small 
variabilities.  
There were limitations in assessing the shell thickness and core diameter. Image J 
software was used for the measurements.  The shell thickness and core diameter needed to be 
measured by drawing a line across the shell or core diameter and measuring the length of the line 
through Image J once the scale was set. Since there was some slight variability in performing 
measurements this way, it is important to note that these shell thicknesses and core diameter 
values are approximations and not exact values. However, an equal number of shell thickness 
measurements for each TEOS amount were taken, to maintain a constant sample size in order to 
obtain more accurate thickness distribution graphs for comparison. The silicon dioxide coating 







4. Conclusion and Summary 
The goal of this research was to assess the reproducibility and feasibility of the producing SiO2 
BiNPs using the synthetic bismuth nanoparticle preparation method and the silicon dioxide shell 
coating method. This was done through analyzing TEM images of data of BiNPs and SiO2 
BiNPs. The TEM Images were analyzed and assessed to reveal nanoparticle shape and size, size 
distributions, and shell thickness. The shape, mean size, size distributions, and coefficients of 
variation of three different trials of the BiNP synthesis were compared and contrasted to assess 
for reproducibility of the synthesis. The silicon dioxide shell coating method was assessed to 
examine the effect varying TEOS amounts had on shell thickness. The SiO2 coating procedure 
was assessed by looking at the morphology, mean shell thickness, shell thickness distribution, 
and coefficients of variation to determine the uniformity and the degree of variability in shell 
coating within each batch.  
From these results, multiple assertions can be made about the elemental bismuth 
nanoparticle synthesis in terms of reproducibility. First, the synthetic bismuth nanoparticle 
preparation method did show a high degree of reproducibility for producing BiNPs of a circular 
morphology. Second, the BiNP synthesis is not reproducible in producing nanoparticles of the 
same size within or between different batches. Third, there is a high degree of reproducibility in 
the synthesis to produce nanoparticles that are of a narrow polydispersity. Fourth, the synthesis is 
highly reproducible in producing nanoparticles within a specific range of 40-80 nm.   
From the results, there are also multiple assertions that can be made about the SiO2 shell 
coating procedure for BiNPs. First, an increase in TEOS amount was positively correlated with 
an increase in SiO2 shell thickness. It may be hypothesized that the TEOS can have a limiting 
effect up to a certain point, where upon changing the amount of TEOS may have little to no 
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effect on the shell thickness. Secondly, the low coefficients of variability, low standard 
deviations, and uniform shell morphology show that the silicon dioxide shell coating procedure 
is able to uniformly coat the bismuth nanoparticles for each TEOS batch amount with small 
variabilities.  
   It is important to assess both procedures for improvements. The BiNP synthetic 
preparation may be improved to yield highly monodisperse nanoparticles with greater 
reproducibility. The SiO2 shell coating can also be improved to coat nanoparticles more 
effectively with even lower variabilities within each batch of different amount of TEOS used. 
However, it is equally important to note the limitations in sample size, analysis methods, and 
experimental errors for the results can lead to a greater degree of variation between and within 
samples for both procedures. It is important to gain more trials and improve experimental and 
analysis methods to further assess for reproducibility and uniformity within both the BiNP 













5. Future Work 
Future studies need to work on improving the size diameter consistency of nanoparticles 
within each batch and between batches. Since previous studies have conducted elemental 
bismuth nanoparticle synthesis under anaerobic conditions, this synthesis provides a novel and 
facile production of bismuth nanoparticles. Hence, this may help to more easily develop 
nanoparticles as potential XCAs under atmospheric conditions, while having less stringent 
experimental conditions. This would make the preparation of such contrast agents much easier. If 
multiple consistent results between batches are achieved, a possible next step would be to test the 
stabilization and effectiveness of these nanoparticles in aqueous or biological media.  
In terms of the silicon dioxide shell coating, the silicon dioxide shell coating may help to 
further stabilize the core shell bismuth nanoparticle. Further studies may examine the stability of 
core shell nanoparticles coated with silicon dioxide in aqueous or biological media. Another 
further study could also examine the impact on fluorescence of the silicon dioxide shell on 
bismuth nanoparticles. The increased stability gained by the SiO2 shell coating may help to not 
only stabilize but increase the fluorescence and particle detectability of the bismuth nanoparticle. 
This would aid the findings of the SiO2 silver nanoparticle study, and provide more support to 










I would like to express my sincere gratitude to my advisor, Dr. Andrea Goforth for continuously 
supporting and mentoring me throughout the research and writing process. Her guidance allowed 
me to learn about nanoparticle chemistry and gain valuable skills and experiences. I would also 
like to thank Hayden Winter for mentoring and teaching me throughout the research process and 
providing me with the opportunity to explore more about bismuth nanoparticle synthesis. 
Additionally, I want to thank all of the Goforth lab members (Colin, James, Christine, Elena, and 
Lydia) for helping and supporting me. They have greatly helped me to understand different 
experimental techniques and answer my questions about the research process. I would also like 
to thank the Portland State University Honors College and the community of professors and 
















[1] Cole, L. E., Ross, R. D., Tilley, J. M., Vargo-Gogola, T., & Roeder, R. K. (2015). Gold 
nanoparticles as contrast agents in x-ray imaging and computed tomography. Nanomedicine, 
10(2), 321+. 
 
[2] Li, X.; Anton, N.; Zuber, G.; Vandamme, T. (2014). Contrast agents for preclinical targeted 
X-ray imaging. Advanced Drug Delivery Reviews, 76, 116–133. 
 
[3] Brown, A. L. (2013). Bismuth Nanoparticles as Medical X-ray Contrast Agents: Synthesis, 
Characterization and Applications. Ph.D. Thesis. Portland State University: USA. 
 
[4] Brenner, D. J.; Hricak, H. (2010). Radiation Exposure From Medical Imaging Time to 
Regulate? Jama, 304(2), 208. 
 
[5] Chest X-ray. Digital Image. Bournemouth private clinic. Web. 
<bournemouthprivateclinic.co.uk>. 
 
[6] Hand X-ray.  Digital Image. Ultimate Medical Library. 18 Nov 2014. Web. 
<ultimatemedical.edu>. 
 
[7] Knee X-ray. Digital Image. California State University Fullerton Risk Management and 
Environmental Health and Safety. Web. < rmehs.fullerton.edu>. 
 
[8] Mcketty, M. H. (1998). The AAPM/RSNA physics tutorial for residents. X-ray 
attenuation. RadioGraphics, 18(1), 151-163.  
 
[9] Hahn, M. A., Singh, A. K., Sharma, P., Brown, S. C., & Moudgil, B. M. (2011). 
Nanoparticles as contrast agents for in-vivo bioimaging: current status and future 
perspectives. Analytical and Bioanalytical Chemistry, 399(1), 3-27.  
 
[10] Wysowski, D. K., & Nourjah, P. (2006). Deaths Attributed to X-Ray Contrast Media on 
U.S. Death Certificates. American Journal of Roentgenology, 186(3), 613-615.  
 
[11] Cormode, D. P., Naha, P. C. and Fayad, Z. A. (2014), Nanoparticle contrast agents for 
computed tomography: a focus on micelles. Contrast Media Mol. Imaging, 9: 37–52. 
 
[12] Alkilany, A. M., & Murphy, C. J. (2010). Toxicity and cellular uptake of gold nanoparticles: 




[13] Brown, A. L., & Goforth, A. M. (2012). PH-Dependent Synthesis and Stability of Aqueous, 
Elemental Bismuth Glyconanoparticle Colloids: Potentially Biocompatible X-ray Contrast 
Agents. Chemistry of Materials, 24(9), 1599-1605.  
 
[14] Wang, F., Tang, R., Yu, H., Gibbons, P. C., & Buhro, W. E. (2008). Size- and Shape-
Controlled Synthesis of Bismuth Nanoparticles. Chemistry of Materials, 20(11), 3656-3662. 
 
[15] He, M., Protesescu, L., Caputo, R., Krumeich, F., & Kovalenko, M. V. (2015). A General 
Synthesis Strategy for Monodisperse Metallic and Metalloid Nanoparticles (In, Ga, Bi, Sb, Zn, 
Cu, Sn, and Their Alloys) via in Situ Formed Metal Long-Chain Amides. Chemistry of 
Materials, 27(2), 635-647. 
 
[16] Aslan, K., Wu, M., Lakowicz, J. R., & Geddes, C. D. (2007). Fluorescent Core−Shell 
Ag@SiO2Nanocomposites for Metal-Enhanced Fluorescence and Single Nanoparticle Sensing 
Platforms. Journal of the American Chemical Society,129(6), 1524-1525. 
 
[17] Winey, M., Meehl, J. B., O’Toole, E. T., & Giddings, T. H. (2014). Conventional 
transmission electron microscopy. Molecular Biology of the Cell, 25(3), 319–323. 
 
 
